The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study
Journal Title: Noropsikiyatri Arsivi - Year 2013, Vol 50, Issue 4
Abstract
Introduction: Findings about the relationship between psychopathology and severity of myasthenia gravis (MG) seem scarce and conflicting. The aim of this study was to investigate the relationship of depressive and anxiety symptoms with disease severity and treatment modalities among a cohort of patients with MG. Methods: Sixty-seven patients, who presented to the neuromuscular outpatient clinic, at a neuropsychiatry hospital in Istanbul, Turkey in a two-month period, were recruited consecutively. A total of 42 patients with MG were invited to participate in the study. None of the patients refused to participate. Severity of MG was assessed according to the Osserman and Genkins classification. The participants were evaluated by a sociodemographic form, the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Hamilton Depression Rating Scale 17-item version (HAM-D), and the Hamilton Anxiety Rating Scale (HAM-A). Results: The patients with stage IIB MG had significantly higher scores on the BAI, HAM-D, HAM-A total and somatic anxiety than those with stage I and IIA MG (p<0.05). Likewise, the patients taking a combination of prednisolone+pyridostigmine/azathioprine had significantly higher scores on the BAI, HAM-D, HAM-A total and somatic anxiety than those taking only prednisolone (p<0.05). Linear regression analysis revealed that disease severity and stressful life events were the factors associated with the HAM-D scores. Disease severity, treatment modalities, and gender were the factors associated with the HAM-A scores. Conclusion: The results of the present study may suggest that patients with relatively more severe MG or those taking a combination of immunosupressive and anticholinesterase medications need psychiatric/psychological evaluation. (Archives of Neuropsychiatry 2013; 50: 295-300)
Authors and Affiliations
Fikret AYSAL, Oğuz KARAMUSTAFALIOĞLU, Başak ÖZÇELİK, Meltem YILMAZ, Nesrin KARAMUSTAFALIOĞLU, Hüseyin YUMRUKÇAL, Onur TANKAYA
Keywords
Related Articles
- EP ID EP151930
- DOI 10.4274/npa.y5611
- Views 100
- Downloads 0
Natalizumab ile Tedavi Edilen Multipl Skleroz Hastalarında PML Risk Değerlendirmesi
Natalizumab (NAB) yineleyici multipl skleroz (MS) formları için denenen monoklonal antikorlar arasında ilk onay alandır. Ancak, bu ilacın MS’deki yüksek etkinliğine rağmen merkezi sinir sisteminde (MSS) JCV infeksiyonu s...
Psikopatolojinin-Psikoterapinin Sınırları ve Eşcinsel Deneyimi Olan Ergenler<br />
Chorea-Ballismus Associated with Hyperglycemia
Chorea-ballismus which is a rare complication of nonketotic hyperglycemia may be the first symptom of type 2 diabetes mellitus. In this paper, we present two patients, who had involuntary movements and were diagnosed as...
Should the Western Aphasia Battery Be Translated into Turkish?
Objective: Aphasia tests are used to classify and diagnose aphasia. Aphasia tests, which can classify aphasia quantitatively, are needed for a standard classification of aphasia and to compare studies performed in differ...
Self-Esteem, Social Phobia and Depression Status in Patients with Epilepsy
Introduction: The increased risk for psychiatric disorders in epilepsy can be related to a number of clinical, psychosocial and biological factors. Due to the unpredictability of seizures and the possibility that they m...